Improving Quality Of Life, Functioning & Well-Being In Individuals Living With Bipolar Disorder 

Bipolar disorder is a lifelong, chronic mental health disorder characterized by extreme shifts in mood that can have a profound negative effect on daily functioning, cognition, and quality of life for individuals living with the disorder.¹ During this webinar, guest speaker Dr. Martha Sajatovic, and Medical Science Liaison, Taylor Ochalek, will address why quality of life may be compromised in individuals with bipolar disorder and review the utility of measurement-based tools. Dr. Sajatovic will then discuss potential advantages of implementing both pharmacological and psychosocial interventions to improve quality of life, functioning and well-being.  

References: 

1. Bonnín CDM, et al. Improving Functioning, Quality of Life, and Well-being in Patients with Bipolar Disorder. Int J Neuropsychopharmacol. 2019 Aug 1;22(8):467-477. 

Featuring:

Martha Sajatovic, MD

Psychiatrist, Director Neurological and Behavioral Outcomes Center, University Hospital Cleveland Medical Center and Professor, Case Western Reserve University School of Medicine

More

Martha Sajatovic, MD holds the Willard Brown Chair in Neurological Outcomes at University Hospitals Cleveland Medical Center (UH CMC) and the Rocco L. Motto Professorship in Child & Adolescent Psychiatry. Dr. Sajatovic directs the Neurological and Behavioral Outcomes Center at UHCMC/Case Western Reserve University. She has subspecialty certification in Behavioral Neurology & Neuropsychiatry. Dr. Sajatovic is a Professor of Psychiatry and Neurology at Case Western Reserve University School of Medicine (CWRU) in Cleveland, Ohio. Dr. Sajatovic is a researcher, educator, and clinician who has devoted herself to studying and treating traditionally, hard-to-treat populations with central nervous system disorders. Dr. Sajatovic’s research interests have focused on neuropsychiatric outcomes of brain disorders across the life-span, including epilepsy, stroke, Alzheimer’s disease, and other types of dementia and Parkinson’s disease. She has authored or co-authored over 250 peer-reviewed publications and has published over 40 book chapters or books on neuropsychiatric topics. Dr. Sajatovic has been a recipient of the Exemplary Psychiatrist Award bestowed by the National Alliance for the Mentally Ill (NAMI), was a Depression and Bipolar Support Alliance (DBSA) Gerald Klerman Investigator Award winner in 2006 and 2016, and in 2018 received the Rebecca Goldberg Kaufman American Epilepsy Society (AES) Clinical Award in Ethical Neuropsychiatry.

Taylor Ochalek, PhD

Medical Science Liaison

Disclaimers

Martha Sajatovic, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. 

Taylor Ochalek is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.  

PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
May 2024    US.CORP.X.24.00150